Therapeutics and Clinical Risk Management

Aims & Scope

Therapeutics and Clinical Risk Managementis an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas. The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal does not accept study protocols, animal-based or cell line-based studies. Case reports/series submitted toTherapeutics and Clinical Risk Managementwill be diverted to theInternational Medical Case Reports Journal(Journal metric data for this journal can be accessedhere). When considering submission of a paper utilizing publicly available data (e.g. SEER), authors should ensure that such studies add significantly to the body of knowledge about a specific disease or relevant phenotype and that they are validated using the authors’ own data through replication in an original sample and functional follow-up. All meta-analyses require a pre-submission check prior to submitting toTherapeutics and Clinical Risk Management. Please complete the pre-submission check formhere.

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Subject Classification